Annual trends of cystectomy complications: A contemporary analysis of the NSQIP database.

[1]  A. Feber,et al.  Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial. , 2022, JAMA.

[2]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[3]  J. McGrath,et al.  Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis. , 2020, European urology.

[4]  A. Mitra,et al.  MP41-04 THE URINARY MICROBIOME AFTER RADICAL CYSTECTOMY AND URINARY DIVERSION , 2020 .

[5]  I. Gill,et al.  Surgical approach as a determinant factor of clinical outcome following radical cystectomy: Does Enhanced Recovery After Surgery (ERAS) level the playing field? , 2019, Urologic oncology.

[6]  N. Fossati,et al.  Comparison of perioperative complications and health‐related quality of life between robot‐assisted and open radical cystectomy: A systematic review and meta‐analysis , 2019, International journal of urology : official journal of the Japanese Urological Association.

[7]  A. G. van der Heijden,et al.  Incidence and microbiology of post-operative infections after radical cystectomy and ureteral stent removal; a retrospective cohort study , 2019, BMC Infectious Diseases.

[8]  G. Haber,et al.  Reducing Readmissions following Radical Cystectomy: Moving Beyond Enhanced Recovery. , 2019, Urology.

[9]  P. Clark,et al.  Decreasing ureteral stent duration following radical cystectomy decreases readmissions and urinary infectious complications. , 2019, Journal of Clinical Oncology.

[10]  I. Thompson,et al.  Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial , 2018, The Lancet.

[11]  D. Brooks,et al.  Morbidity Associated with Urinary Diversion in the United States: A Contemporary Evaluation Using the NSQIP Database , 2017, Urology practice.

[12]  Yair Lotan,et al.  Treatment of Non‐Metastatic Muscle‐Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline , 2017, The Journal of urology.

[13]  J. Catto,et al.  Prospective Implementation of Enhanced Recovery After Surgery Protocols to Radical Cystectomy. , 2017, European urology.

[14]  S. Daneshmand,et al.  90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study , 2017, World Journal of Urology.

[15]  M. Cooperberg,et al.  Impact of frailty on complications in patients undergoing common urological procedures: a study from the American College of Surgeons National Surgical Quality Improvement database , 2016, BJU international.

[16]  N. Smith,et al.  The effect of broader, directed antimicrobial prophylaxis including fungal coverage on perioperative infectious complications after radical cystectomy. , 2016, Urologic oncology.

[17]  S. Hohmann,et al.  Association of hospital participation in a surgical outcomes monitoring program with inpatient complications and mortality. , 2015, JAMA.

[18]  Anirban P. Mitra,et al.  Enhanced recovery protocol after radical cystectomy for bladder cancer. , 2014, The Journal of urology.

[19]  K. Lassen,et al.  Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS(®)) society recommendations. , 2013, Clinical nutrition.

[20]  D. Gillatt,et al.  Introduction of an enhanced recovery protocol for radical cystectomy , 2008, BJU international.

[21]  E. Wallen,et al.  Fast track program in patients undergoing radical cystectomy: results in 362 consecutive patients. , 2010, Journal of the American College of Surgeons.

[22]  B. Bochner,et al.  Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. , 2009, European urology.